Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary sclerosing cholangitis].

A Stiehl1

  • 1Medizinische Universitätsklinik Heidelberg. adolf_stiehl@med.uni-heidelberg.de

Der Internist
|January 22, 2004
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis (PSC) is a chronic liver disease often linked to ulcerative colitis. Early treatment with ursodeoxycholic acid (UDCA) can improve liver histology and prevent disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC - authors' reply.

Alimentary pharmacology & therapeutics·2014
Same author

Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis.

Alimentary pharmacology & therapeutics·2014
Same author

In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment.

Digestive diseases and sciences·2011
Same author

Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study.

Endoscopy·2008
Same author

Retrieval of the rat canalicular conjugate export pump Mrp2 is associated with a rearrangement of actin filaments and radixin in bile salt-induced cholestasis.

European journal of medical research·2008
Same author

Poor outcome in progressive sclerosing cholangitis after septic shock.

Endoscopy·2008
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Area of Science:

  • Hepatology and Gastroenterology
  • Chronic cholestatic liver diseases
  • Autoimmune and inflammatory conditions

Context:

  • Primary sclerosing cholangitis (PSC) is a prevalent adult cholestatic liver disease.
  • Characterized by fibrosing inflammation and bile duct obliteration.
  • Frequently co-occurs with ulcerative colitis, increasing cancer risks.

Purpose:

  • To highlight the importance of early diagnosis and treatment for PSC.
  • To discuss the efficacy of ursodeoxycholic acid (UDCA) in managing PSC.
  • To outline management strategies for different disease stages.

Summary:

  • PSC involves progressive bile duct damage and is associated with increased cancer incidence.
  • Immunosuppressive therapies show limited efficacy.

Related Experiment Videos

  • Ursodeoxycholic acid (UDCA) improves liver histology and early endoscopic dilatation of stenoses is effective.

    • Impact:

    • Early UDCA treatment may prevent advanced PSC stages.
    • Endoscopic dilatation offers effective management for ductal stenoses.
    • Liver transplantation remains the indicated treatment for end-stage PSC.